Anthropic Just Paid $400M for a Team of 10. Here's Why That Makes Sense.

Eight months. That's how long Coefficient Bio existed before Anthropic bought it for $400 million in stock. No public product. No disclosed revenue. No conventional traction metrics. Just a small team of fewer than 10 people, most of them former Genentech computational biology researchers, and one very large claim: they were building artificial superintelligence for science. Anthropic paid up anyway. And if you look at what they've been building in healthcare and life sciences over the past year, this acquisition is less of a surprise and more of a logical endpoint. Who Is Coefficient Bio? Coefficient Bio was founded roughly eight months ago by Samuel Stanton and Nathan C. Frey. Both came from Prescient Design, Genentech's computational drug discovery unit. Frey led a group there working on biological foundation models and novel machine learning approaches to biomolecule design. The startup was backed by Dimension, a VC firm that reportedly ended up with a 38,513% IRR on the deal. That